Polen Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $966K | Sell |
|
|||||
|
2021
Q4 | $1.22M | Sell |
|
|||||
|
2021
Q3 | $1.3M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $968M | Buy |
|
|||||
|
2020
Q3 | $1.08B | Buy |
|
|||||
|
2020
Q2 | $1.15B | Buy |
|
|||||
|
2020
Q1 | $840M | Buy |
|
|||||
|
2019
Q4 | $629M | Buy |
|
|||||
|
2019
Q3 | $456M | Buy |
|
|||||
|
2019
Q2 | $496M | Sell |
|
|||||
|
2019
Q1 | $658M | Buy |
|
|||||
|
2018
Q4 | $555M | Sell |
|
|||||
|
2018
Q3 | $601M | Buy |
|
|||||
|
2018
Q2 | $512M | Buy |
|
|||||
|
2018
Q1 | $489M | Buy |
|
|||||
|
2017
Q4 | $522M | Buy |
|
|||||
|
2017
Q3 | $614M | Sell |
|
|||||
|
2017
Q2 | $779M | Buy |
|
|||||
|
2017
Q1 | $573M | Buy |
|
|||||
|
2016
Q4 | $492M | Buy |
|
|||||
|
2016
Q3 | $326M | Buy |
|
|||||
|
2016
Q2 | $275M | Buy |
|
|||||
|
2016
Q1 | $255M | Buy |
|
|||||
|
2015
Q4 | $340M | Buy |
|
|||||
|
2015
Q3 | $268M | Buy |
|
|||||
|
2015
Q2 | $283M | Sell |
|
|||||
|
2015
Q1 | $256M | Buy |
|
|||||
|
2014
Q4 | $222M | Sell |
|
|||||
|
2014
Q3 | $199M | Buy |
|
|||||
|
2014
Q2 | $58.9M | Sell |
|
|||||
|
2014
Q1 | $65.8M | Buy |
|
|||||
|
2013
Q4 | $482K | Hold |
|
|||||
|
2013
Q3 | $548K | Hold |
|
|||||
|
2013
Q2 | $394K | Buy |
|